Analysts who follow SAGE Therapeutics Inc (SAGE) on average expect it to gain 89.03% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns SAGE an Analyst Ranking of 29, which means it ranks higher than 29 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating SAGE a Buy today. Find out what this means to you and get the rest of the rankings on SAGE!